Gemigliptin, a novel dipeptidyl peptidase-4 (DPP-4) inhibitor, has emerged as a promising therapeutic option for individuals with type 2 diabetes mellitus. With its unique mechanism of action, favorable efficacy, and safety profile, gemigliptin represents a significant advancement in the management of diabetes.
Understanding Gemigliptin
Gemigliptin belongs to a class of medications known as...
The global U.S. Medical Foods Market is estimated to be valued at US$ 22,328.51 Mn in 2023 and is expected to exhibit a CAGR of 17% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
SWOT Analysis:-
· Strength: Specialized formulation addressing the underlying disease pathology....
The Tinnitus Management Market is estimated to be valued at US$ 2.54 Billion in 2022 and is expected to exhibit a CAGR of 3.5% over the forecast period from 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
SWOT Analysis
· Strength: The tinnitus management market has strong growth opportunities due to the...
Visual impairment refers to a loss of vision or sight that cannot be corrected with glasses or contact lenses. This includes conditions such as cataracts, glaucoma, diabetic retinopathy, and age-related macular degeneration. These diseases and disorders are usually age-related and are becoming more common as the global population ages. Visual impairment products help people with low vision by...